why am i gaining weight on glp 1 Surprising Causes of Gain and When to Worry Why Am I Gaining Weight

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: From randomised trials to clinical practice

In the COR-II trial, participants lost about 6.4% of body weight at 56 weeks

Phase 3 trials are the final and most in-depth study phase before a drug is approved for treatment

Benefits and Challenges Compared to Injections The appeal of a GLP-1 pill is easy to understand

February 2, 2026: FDA Published Second Safety Label Change of 2026 for Zepbound Eli Lillys popular weight-loss drug Zepbound had a second safety label update in January 2026

For non-IBD IMIDs, there were three human in vitro studies and eight human clinical studies